Artivion, Inc. (AORT)

37.48 -0.48 (-1.25%) USD  |  NYSE  |  Apr 15, 16:00
37.48 0.00 (0.00%) After-Hours: 20:00
More

Artivion Research and Development Expense (Annual) : 30.99M for Dec. 31, 2025

Research and Development Expense (Annual) Chart

View Research and Development Expense (Annual) for AORT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Annual) Range, Past 5 Years

View Research and Development Expense (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Annual) Benchmarks

View Research and Development Expense (Annual) Benchmarks
Start Trial
NeuroOne Medical Technologies Corp. 4.983M
Edwards Lifesciences Corp. 1.079B
Zimmer Biomet Holdings, Inc. 458.50M
PetVivo Holdings, Inc. 1.583M
Nutriband, Inc. 3.119M